Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Berentsen S, Barcellini W. Autoimmune hemolytic anemias. N Engl J Med. 2021;385:1407–19.
2. Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sørbø JH, Tjønnfjord GE. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica. 2006;91:460–6.
3. Mullins M, Jiang X, Bylsma LC, Fryzek JP, Reichert H, Chen EC, Kummar S, Rosenthal A. Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization. Blood Adv. 2017;1:839–48.
4. Röth A, Barcellini W, D’Sa S, Miyakawa Y, Broome CM, Michel M, Kuter DJ, Jilma B, Tvedt THA, Fruebis J, Jiang X, Lin S, Reuter C, Morales-Arias J, Hobbs W, Berentsen S. Sutimlimab in cold agglutinin disease. N Engl J Med. 2021;384:1323–34.
5. Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A. British Society for Haematology. the diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017;176:395–411.